|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/14 | |
| A61K 31/16 | |||
| A61K 31/165 | |||
| A61K 31/55 |
| (11) | Patento numeris | 2077822 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07815703.9 |
| Europos patento paraiškos padavimo data | 2007-09-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-07-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/BR2007/000261 |
| Data | 2007-09-27 |
| (87) | Numeris | WO 2008/037044 |
| Data | 2008-04-03 |
| (30) | Numeris | Data | Šalis |
| PI0604387 | 2006-09-27 | BR |
| (72) |
NEGR O, Alexandre Funari, BR
|
| (73) |
Medley S.A. Ind stria Farmacźutica,
R. Macedo Costa, 55, Jd. Santa Genebra, 13080-180 Campinas - SP,
BR
|
| (54) | OXCARBAZEPINE-CONTAINING ORAL FORMULATION AND A PROCESS TO OBTAIN THE SAME |
| OXCARBAZEPINE-CONTAINING ORAL FORMULATION AND A PROCESS TO OBTAIN THE SAME |